Clinical Trials Browser

Phase 3 × OTHER × bicalutamide × Clear all

NCT04513717 2026-01-14

Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial

Phase 3 Active not recruiting

Prostatic Neoplasms

NCT00541047 2023-11-13

RADICALS - Radiotherapy and Androgen Deprivation In Combination After Local Surgery

Phase 3 Completed

GenitourinaryOther

Prostatic Neoplasms, Sexual Dysfunction, Physiological

NCT05019846 2023-04-18

SPA

Phase 3 Recruiting

Prostatic Neoplasms

NCT00055731 2023-01-18

Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse

Phase 3 Completed

Prostatic Neoplasms

NCT03055312 2021-01-28

SYSUCC-007

Phase 3 Terminated

Triple Negative Breast Neoplasms

NCT00003645 2020-04-28

Randomized Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for Recurrence

Phase 3 Terminated

64 enrolled 12 charts

Prostatic Neoplasms

NCT00002855 2018-10-31

Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer

Phase 3 Completed

Prostatic Neoplasms

NCT00243646 2016-04-14

Implant and External Radiation for Prostate Cancer With or Without Hormonal Therapy: A Prospective Randomized Trial

Phase 3 Terminated

Prostatic Neoplasms

NCT00067015 2015-12-22

Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer

Phase 3 Completed

Prostatic Neoplasms

NCT02382094 2015-03-06

Clinical Trial to Study Quality of Life in Prostate Cancer Patients by Randomizing Anti-androgen Versus Total Androgen Blockage Prior to Curative Intended Radiation Therapy

Phase 3 Completed

Prostatic Neoplasms

NCT00175396 2014-03-17

Androgen Suppression Combined With Elective Nodal and Dose Escalated Radiation Therapy

Phase 3 Unknown

Prostatic Neoplasms